Tech Company Financing Transactions
Bantam Pharmaceutical Funding Round
Bantam Pharmaceutical secured a $25 million Seed funding round on 9/20/2021. Backers included private investors.
Transaction Overview
Company Name
Announced On
9/20/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Seed
Investors
private investors (Lionel Goldfrank)
Proceeds Purpose
The company intends to use the funds to finalize its ongoing IND-enabling activities for its lead program, BTM-3566, and consummate preparations for first in human clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
424 West 33rd St. 540
New York, NH 10001
USA
New York, NH 10001
USA
Phone
Website
Email Address
Overview
Bantam operates in a highly cost efficient manner. The management team has deep experience in oncology drug discovery and development including R&D and partnering. Bantam's scientific advisory board is comprised of prominent academic and industry leaders with drug development and executive leadership roles in early stage and global pharmaceutical companies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Stocum
Chief Scientific Officer
Matthew Kostura
Browse more venture capital transactions:
Prev: 9/20/2021: Roboflow venture capital transaction
Next: 9/20/2021: Elodie Games venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs